Back to Search
Start Over
Oral vitamin B 12 supplement is delivered to the distal gut, altering the corrinoid profile and selectively depleting Bacteroides in C57BL/6 mice.
- Source :
-
Gut microbes [Gut Microbes] 2019; Vol. 10 (6), pp. 654-662. Date of Electronic Publication: 2019 May 07. - Publication Year :
- 2019
-
Abstract
- Vitamin B <subscript>12</subscript> is a critical nutrient for humans as well as microbes. Due to saturable uptake, high dose oral B <subscript>12</subscript> supplements are largely unabsorbed and reach the distal gut where they are available to interact with the microbiota. The aim of this study was to determine if oral B <subscript>12</subscript> supplementation in mice alters 1) the concentration of B <subscript>12</subscript> and related corrinoids in the distal gut, 2) the fecal microbiome, 3) short chain fatty acids (SCFA), and 4) susceptibility to experimental colitis. C57BL/6 mice (up to 24 animals/group) were supplemented with oral 3.94 µg/ml cyanocobalamin (B <subscript>12</subscript> ), a dose selected to approximate a single 5 mg supplement for a human. Active vitamin B <subscript>12</subscript> (cobalamin), and four B <subscript>12</subscript> -analogues ([ADE]CN-Cba, [2Me-ADE]CN-Cba, [2MeS-ADE]CN-Cba, CN-Cbi) were analyzed in cecal and fecal contents using liquid chromatography/mass spectrometry (LC/MS), in parallel with evaluation of fecal microbiota, cecal SCFA, and susceptibility to dextran sodium sulfate (DSS) colitis. At baseline, active B <subscript>12</subscript> was a minor constituent of overall cecal (0.86%) and fecal (0.44%) corrinoid. Oral B <subscript>12</subscript> supplementation increased active B <subscript>12</subscript> at distal sites by >130-fold (cecal B <subscript>12</subscript> increased from 0.08 to 10.60 ng/mg, fecal B <subscript>12</subscript> increased from 0.06 to 7.81 ng/ml) and reduced microbe-derived fecal corrinoid analogues ([ADE]CN-Cba, [2Me-ADE]CN-Cba, [2MeS-ADE]CN-Cba). Oral B <subscript>12</subscript> had no effect on cecal SCFA. Microbial diversity was unaffected by this intervention, however a selective decrease in Bacteroides was observed with B <subscript>12</subscript> treatment. Lastly, no difference in markers of DSS-induced colitis were detected with B <subscript>12</subscript> treatment.
- Subjects :
- Administration, Oral
Animals
Bacteroides growth & development
Cecum chemistry
Colitis chemically induced
Colitis diet therapy
Dextran Sulfate toxicity
Fatty Acids, Volatile analysis
Feces chemistry
Feces microbiology
Gastrointestinal Microbiome drug effects
Mice, Inbred C57BL
Vitamin B 12 pharmacology
Vitamin B Complex pharmacology
Bacteroides drug effects
Corrinoids analysis
Dietary Supplements analysis
Vitamin B 12 administration & dosage
Vitamin B Complex administration & dosage
Subjects
Details
- Language :
- English
- ISSN :
- 1949-0984
- Volume :
- 10
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Gut microbes
- Publication Type :
- Academic Journal
- Accession number :
- 31062653
- Full Text :
- https://doi.org/10.1080/19490976.2019.1597667